Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance.
- NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_assertion description "[CCN1, a candidate target for zoledronic acid treatment in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance.
- NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_assertion evidence source_evidence_literature NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance.
- NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_assertion SIO_000772 21393426 NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance.
- NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_assertion wasDerivedFrom befree-20140225 NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance.
- NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_assertion wasGeneratedBy ECO_0000203 NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance.
- befree-20140225 importedOn "2014-02-25" NP511892.RAgf9zB8xOiBHHptbNdNGqdgHrI63O_GYLvThF-IiRh5o130_provenance.